Intensive Lipid-Lowering Therapy for Patients With Aortic Stenosis † † Conflicts of interest: Dr Pedersen has received research grants from Merck Sharp & Dohme, Norway; Merck/Schering-Plough, North Wales, Pennsylvania; and Pfizer, Inc., New York, New York, and consultant honoraria and speaker's fees from Merck Sharp & Dohme; Merck/Schering-Plough; Pfizer, Inc.; AstraZeneca, Wilmington, Delaware; and Merck KgaA, Darmstadt, Germany.
Titel:
Intensive Lipid-Lowering Therapy for Patients With Aortic Stenosis † † Conflicts of interest: Dr Pedersen has received research grants from Merck Sharp & Dohme, Norway; Merck/Schering-Plough, North Wales, Pennsylvania; and Pfizer, Inc., New York, New York, and consultant honoraria and speaker's fees from Merck Sharp & Dohme; Merck/Schering-Plough; Pfizer, Inc.; AstraZeneca, Wilmington, Delaware; and Merck KgaA, Darmstadt, Germany.
Tijdschrift beschrijving